Indefinite Delivery Contract 36C25625D0089

Award Date 6/30/25
Last Date to Order 6/29/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) valued at $167,300 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical laboratory equipment. The contract, which has a period of performance through June 30, 2030, provides for the delivery of Roche LIAT consumables, including test kits and controls for COVID-19, Influenza A/B, RSV, and Group A Streptococcus testing, to the VA's Veterans...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the procurement of Ventana immunohistochemical reagents and associated laboratory equipment, supplies, and services. This single-award IDC has a potential value of $2,442,399.60 over a 5-year ordering period from March 2024 to March 2029. Under this IDC, the VA VHA Network Contracting Office 17...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products, laboratory instruments, and associated medical equipment and supplies. The BPA, valued at up to $962,399.40, enables the VA's Veterans Integrated Service Network 17 to acquire Roche's Ventana Benchmark Ultra reagents, equipment, and supplies to support diagnostic pathology...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a series of firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The total ceiling value of the IDC is $2,403,690.00, with the most recent delivery order valued at $480,738.00 and a performance period ending on September 30, 2025. The delivery orders are...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The $487,747.35 BPA contract, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), will provide the VA with critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The contract supports the provision of...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA-VHA VISN 17) awarded a single-award Indefinite Delivery Contract (IDC) valued at $1,963,596.60 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide Roche Ventana reagents and consumables. This 5-year IDC serves as a vehicle for the VA to issue fixed-price delivery orders against, as needed, to support pathology and histology services at VA medical...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a Blanket Purchase Agreement (BPA) contract valued at $5,223,493.58 to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. Under this multiple award IDV, Roche will provide VENTANA histology reagents and supplies to support laboratory operations at VA medical centers in the VISN 1 network covering the northeastern U.S. The...
  • 36C25625D0089
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $1.56 million IDC, with a period of performance through June 2030, is for the service, maintenance, and supply of Roche Ventana instruments used by the VA's Veterans Integrated Service Network 16.

This procurement was not set aside for any specific business category. It was awarded as a sole source contract under FAR Parts 12 and 13, as the VA determined that Roche Diagnostics is the only vendor capable of providing the required immunohistology instruments, chemicals, and reagents for the Ventana stainers used by the Central Arkansas Veterans Healthcare System. The contract includes a clause addressing gray market and counterfeit items, requiring the awardee to be an original equipment manufacturer, authorized dealer, distributor, or reseller.

Generated 7/1/25, 2:22 PM